ARAV — Aravive Income Statement
0.000.00%
Last trade - 00:00
- $2.95m
- -$5.59m
- $9.14m
- 17
- 44
- 12
- 13
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.37 | 4.75 | 5.68 | 7.44 | 9.14 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 76.8 | 26.5 | 36.5 | 48.1 | 80 |
Operating Profit | -75.4 | -21.8 | -30.8 | -40.6 | -70.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -76.3 | -18.2 | -30.5 | -39.2 | -76.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -76.3 | -18.2 | -30.5 | -39.2 | -76.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -76.3 | -18.2 | -30.5 | -39.2 | -76.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -76.3 | -18.2 | -30.5 | -39.2 | -76.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.72 | -1.57 | -1.57 | -1.95 | -2.1 |